Explore our media
Learn more about ACTO and the life sciences industry at large through ACTO’s podcast, blogs, events, and more
Featured blogs
Episode 6 | Arif
Creating Controlled Intelligence: AI Support for Pharmaceutical Field Reps
January 16, 2025
Part 3 – After an extended holiday break, we bring you the final post in our AI Series. Our first blog covered the ABCs of Artificial Intelligence (AI). The second post discussed what pharma executives need to consider to ensure a responsible AI implementation. Today, we go through a use case that can uplift field rep effectiveness and efficiency, while fostering
Episode 6 | Arif
What Pharma Must Know About Responsible AI Implementation
December 17, 2024
Part 2 – Our first blog covered the ABCs of Artificial Intelligence (AI) and AI’s evolution. This post discusses key issues pharma executives must consider to ensure responsible, compliant, and successful AI implementation within their organizations. The stakes for AI adoption in the pharmaceutical industry have never been higher. A survey of healthcare and life science companies found that 93%
Pulse is your ultimate source of relevant and innovative strategy
Subscribe today to stay up to date in all thing industry
Subscribe
Recent Articles
Episode 6 | Arif
Creating Controlled Intelligence: AI Support for Pharmaceutical Field Reps
January 16, 2025
Part 3 – After an extended holiday break, we bring you the final post in our AI Series. Our first blog covered the ABCs of Artificial Intelligence (AI). The second post discussed what pharma executives need to consider to ensure a responsible AI implementation. Today, we go through a use case that can uplift field rep effectiveness and efficiency, while fostering
Episode 6 | Arif
What Pharma Must Know About Responsible AI Implementation
December 17, 2024
Part 2 – Our first blog covered the ABCs of Artificial Intelligence (AI) and AI’s evolution. This post discusses key issues pharma executives must consider to ensure responsible, compliant, and successful AI implementation within their organizations. The stakes for AI adoption in the pharmaceutical industry have never been higher. A survey of healthcare and life science companies found that 93%